<-- nev left start -->

Avanafil USP

Avanafil USP
Avanafil USP
Product Description
Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is sold under the brand names Stendra and Spedra.

Molar mass: 483.96 g·mol−1

ATC code: G04BE10 (WHO)

License data: EU EMA: by INN; US DailyMed: Avanafil; US FDA: Avanafil

PubChem CID: 9869929

AHFS/Drugs.com: Monograph

DrugBank: DB06237
Contact Us

B-304, Nilamber Edifice B/H, Bright school, Vasna Bhayli,, Vadodara, Gujarat, 391410, India
Phone :+918035063506